Advocacy intelligence hub — real-time data for patient organizations
Chiesi Farmaceutici S.p.A.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Lamzede
(VELMANASE ALFA-TYCV)Orphan drugChiesi USA, Inc.
Allan M Lund, MD
Copenhagen University Hospital, Center for Metabolic Diseases, Department for Clinical Genetics
Paul Orchard, MD, MD
University of Minnesota Medical Center
📍 MINNEAPOLIS, MN
Paul Szabolcs, MD
UPMC Children's Hospital of Pittsburgh
📍 Pittsburgh, Pennsylvania
Allan M. Lund, MD
Department of Clinical Genetics, Juliane Marie Centre, Region Hovedstaden, Copenhagen University hospital, Denmark
Dag Malm, MD
Department of Medicine, University of Tromsoe
Joanne Kurtzberg, MD, M.D
Duke University
📍 DURHAM, NC